Concord Drugs Limited (CDL) is incorporated as a Limited Company on 24th April
1995 with the Registrar of companies, Andhra Pradesh. The registered office of
the Company is situated at Survey No. 249, Brahmanpally Village, Hayatnagar
Mandal, R.R. District, Hyderabad-501511
Concord Drugs Limited was established in 1995 to manufacture and market
innovative pharmaceutical products. Concord's three core product areas are
generics, branded and specialty pharmaceuticals. The Company ranks among the top
generics suppliers in India. Manufacturers of AMCRYLATE [ISO Amyl
2-Cyanoacrylate] a sterile tissue adhesive used in for sutureless surgeries
first time in Asia in collaboration with Indian Institute of Chemical Technology
[IICT], Hyderabad a premier CSIR Laboratory. The Technology Information,
Forecasting and Assessment Council [TIFAC], New Delhi has helped the company to
mass produce `AMCRYLATE' and bring it to Indian consumers. TIFAC was also
associated in providing Techno-managerial guidance to the Company. The product
is patented in India for Concord Drugs Limited. Further the Company has
established Unit-II or Phase-II at Roorkee, Uttrakhand in 2005 for manufacturing
of Tablets & Capsules.
AMCRYLATE is non-pigmented, non-toxic,
non-allergic, bacteriostatic and bio-static adhesive. It allows rapid wound
closure with minimal scarring, reduces the risk of post surgical infection and
trauma, besides being simple and safe to use.
Also set-up a plant for Small
Volume Parenterals in liquid ampoules/vials and powder Parenterals and also
Tablets & Capsules with Betalactum & Non-Betalactum both sections.
2015
-Concord Drugs Ltd are listed and admitted to dealings on the Exchange in the list of 'DT' Group Securities.
|